NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings

NCT06854029 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

450

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Opioid Use Disorder
Incarceration; Lens

Interventions

DRUG: Cabotegravir Injection
DRUG: Cabotegravir Pill
DRUG: Buprenorphine injection
DRUG: Buprenorphine Pill

Sponsor

Duke University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]